This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
 
Nearly two months after Digene sued Third Wave Technologies for allegedly infringing its human papillomavirus intellectual property, Third Wave last week filed a countersuit with the US District Court for the Western District of Wisconsin, alleging that Digene has “abused its monopoly power to thwart competition” in the HPV diagnostics market.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.